Beta Bionics Price Target Raised to $23.00/Share From $22.00 by Truist Securities
Ratings actions
This is a real-time flash headline. A verified provider body is not available, so SquawkNews does not present it as a full article.
Ratings actions
This is a real-time flash headline. A verified provider body is not available, so SquawkNews does not present it as a full article.